Wells Fargo & Company Hutchmed (China) LTD Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

A detailed history of Wells Fargo & Company transactions in Hutchmed (China) LTD stock. As of the latest transaction made, Wells Fargo & Company holds 12 shares of HCM stock, worth $239. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 12 -0.0%

Holding current value

$239

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$12.08 - $18.56 $144 - $222	12 New	12 $0
Q2 2023 Aug 15, 2023	BUY	$10.78 - $17.73 $161 - $265	15 Added 93.75%	31 $0
Q4 2022 Feb 13, 2023	SELL	$7.65 - $15.51 $1,231 - $2,497	-161 Reduced 90.96%	16 $0
Q3 2022 Nov 14, 2022	SELL	$8.63 - $15.52 $830,749 - $1.49 Million	-96,263 Reduced 99.82%	177 $1,000
Q2 2022 Aug 12, 2022	SELL	$8.59 - $20.77 $503,442 - $1.22 Million	-58,608 Reduced 37.8%	96,440 $1.22 Million
Q1 2022 May 16, 2022	BUY	$15.52 - $35.65 $535,083 - $1.23 Million	34,477 Added 28.59%	155,048 $2.93 Million
Q4 2021 Feb 14, 2022	SELL	$28.89 - $35.33 $19,645 - $24,024	-680 Reduced 0.56%	120,571 $4.23 Million
Q3 2021 Nov 15, 2021	SELL	$35.66 - $42.94 $129,802 - $156,301	-3,640 Reduced 2.91%	121,251 $4.44 Million
Q2 2021 Aug 16, 2021	SELL	$23.7 - $39.27 $1.16 Million - $1.92 Million	-48,972 Reduced 28.17%	124,891 $4.9 Million
Q1 2021 May 13, 2021	SELL	$27.01 - $36.8 $652,777 - $889,382	-24,168 Reduced 12.2%	173,863 $4.91 Million
Q4 2020 Feb 09, 2021	BUY	$27.51 - $34.36 $81,457 - $101,739	2,961 Added 1.52%	198,031 $6.34 Million
Q3 2020 Nov 05, 2020	BUY	$25.8 - $34.61 $938,578 - $1.26 Million	36,379 Added 22.92%	195,070 $6.3 Million
Q2 2020 Aug 13, 2020	BUY	$17.65 - $28.05 $1.02 Million - $1.62 Million	57,910 Added 57.46%	158,691 $4.38 Million
Q1 2020 May 14, 2020	BUY	$15.19 - $29.51 $1.53 Million - $2.97 Million	100,781 New	100,781 $1.8 Million

Others Institutions Holding HCM

# of Institutions

Shares Held

8.25M

Call Options Held

3.8K

Put Options Held

2.4K

View Full List

About HUTCHMED (China) Ltd

Ticker HCM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 172,955,008
Market Cap $3.45B
Description
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...

More about HCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Hutchmed (China) LTD Transaction History